Skip to main content
Signal8

Shen Ethan PhD

SEC insider (Form 3/4/5 filer). CIK 0002099921. CEO at YD Bio Ltd (YDES) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 14, 2026. Located in TAIPEI CITY.

Companies Shen Ethan PhD has filed insider reports for

  • YD Bio Ltd (YDES): Director, Officer, CEO
  • SL Science Holding Ltd (SLBT): Director, Officer, Chief Technology Officer
Shen Ethan PhD profile photo

Shen Ethan PhD

CIK: 0002099921

Transaction Breakdown

Open Market Buys (P)3 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

YD Bio Ltd logo
YDES

YD Bio Ltd

DirectorOfficer
SL Science Holding Ltd logo
SLBT

SL Science Holding Ltd

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • YD Bio Ltd logo
    YDES

    YD Bio Ltd

    Sep 14, 2026
    Purchase
    Direct
    12.7K shares at avg. $3.85$49K
  • YD Bio Ltd logo
    YDES

    YD Bio Ltd

    Sep 9, 2026
    Purchase
    Direct
    3.1K shares at avg. $3.93$12K
  • YD Bio Ltd logo
    YDES

    YD Bio Ltd

    Sep 4, 2026
    Purchase
    Direct
    18.4K shares at avg. $3.67$67K

1-3 of 3